Grants for Public and State controlled institutions of higher education - Health
Explore 196 grant opportunities
Application Deadline
Jul 22, 2024
Date Added
May 16, 2024
The purpose of the Medical Student Education (MSE) Program is to provide support to public medical schools in the top quintile of states with a projected primary care physician shortage to expand or support education for medical students preparing to become physicians. The program is designed to prepare and encourage medical students in these schools to choose residencies and careers in primary care and serve tribal, rural, and/or medically underserved communities in those states after they complete their residency.
Application Deadline
Dec 5, 2024
Date Added
May 15, 2024
This initiative will support multi-level and/or multi-domain intervention research to reduce disparities in liver diseases and liver cancer among populations who experience health disparities in the United States (US).
Application Deadline
Jan 8, 2025
Date Added
May 9, 2024
This funding opportunity supports small-scale research projects at undergraduate-focused institutions to enhance research capabilities and engage students in biomedical research.
Application Deadline
Not specified
Date Added
May 9, 2024
This grant provides funding to undergraduate-focused institutions to support small-scale clinical trials that engage students in meaningful biomedical research experiences.
Application Deadline
Jun 27, 2024
Date Added
May 8, 2024
The Pfizer Sickle Cell Disease (SCD) Fellowship Grant is designed to bolster the number of fellowship programs focused on hematologists who specialize in the treatment of adults with sickle cell disease. This initiative is part of Pfizer Global Medical Grants' broader strategy to support healthcare community-led initiatives that enhance patient outcomes in critical areas of unmet medical need, aligning with Pfizer’s own medical and scientific strategies. The grant aims to enhance the quality of care for sickle cell patients by funding institutions that provide comprehensive training and research opportunities in the field. Specifically, the program supports both established and newly developed fellowship programs that include a robust curriculum in clinical practice, independent research, and education to deepen the scientific understanding of SCD. The fellowship is structured to foster an environment of expert mentorship and significant independent research opportunities. Research activities encouraged under this grant include observational studies and outcomes research that focus on the disease itself, screening tools, and their impact on patient health improvement. Grant funding is set at a maximum of $100,000 for a one-year fellowship, aiming to cover direct costs associated with the fellow’s training and research but explicitly excluding overhead or indirect costs. This financial support underlines Pfizer's commitment to advancing healthcare by investing directly in the development of professionals who are dedicated to improving patient outcomes in the field of sickle cell disease. Key to the grant’s operational framework is compliance with stringent regulatory requirements, including the U.S. Physician Payments Sunshine Act. This act mandates detailed reporting of all transfers of value to ensure transparency and maintain public trust in healthcare practices. The fellowship’s funding structure is designed to be transparent, with specific provisions to prevent any of the funds from benefiting Pfizer's business interests directly or indirectly. Overall, the Pfizer SCD Fellowship embodies a strategic effort to cultivate talent and advance knowledge in a critical area of healthcare, ensuring that the supported programs maintain high standards of integrity and contribute significantly to the field's body of knowledge and patient care practices.
Application Deadline
Jun 20, 2024
Date Added
May 8, 2024
The Pfizer Fellowship Grant for Transthyretin Cardiac Amyloidosis is a competitive grant initiative aimed at advancing the professional development of healthcare professionals specializing in the diagnosis and management of ATTR cardiac amyloidosis. This grant is dedicated to enhancing academic and clinical understanding of the disease through research and education. Offered to U.S.-based academic institutions, the program supports fellowship roles for Cardiologists or Heart Failure Advanced Practice Providers, emphasizing a balance of clinical practice, research, and educational outreach. The grant ensures that the supported activities are independent of Pfizer’s commercial interests, focusing on fostering substantial advancements in the field of cardiac health.
Application Deadline
Not specified
Date Added
May 8, 2024
This funding opportunity is designed for organizations that provide accredited medical education to healthcare professionals, ensuring their programs meet ethical standards and enhance professional development in specific therapeutic areas.
Application Deadline
Jul 8, 2024
Date Added
May 4, 2024
NIEHS invites applications for cooperative agreements to support the development of model programs for the training and education of workers engaged in activities related to hazardous materials and waste generation, removal, containment, transportation and emergency response. This funding opportunity announcement aims to prevent work-related harm through safety and health training. The training programs will transmit skills and knowledge to workers in how best to protect themselves and their communities from exposure to hazardous materials encountered during hazardous waste operations, hazardous materials transportation, environmental restoration of contaminated facilities or chemical emergency response. A variety of sites, such as those involved with chemical waste cleanup and remedial action and transportation-related chemical emergency response, may pose severe health and safety concerns to workers and the surrounding communities. These sites contain many hazardous substances, sometimes unknown, and often a site is uncontrolled. A major goal of the Worker Training Program (WTP) is to support institutional competency-building for the development and delivery of model training and education programs.
Application Deadline
Nov 15, 2024
Date Added
Apr 23, 2024
The National Human Genome Research Institute (NHGR) intends to promote a new initiative by publishing a Notice of Funding Opportunity (NOFO) to advance scholarship on the ethical, legal, and social implications (ELSI) of advances in human genetics or genomics, enhance ELSI research teams, build ELSI research capacity, and broaden the ELSI workforce.The intended NOFO will be based on aconceptrecently approved by the National Advisory Council on Human Genome Research and accompanyingdiscussion. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects, and to consult with NIH following release of the intended NOFO to submit responsive applications. The NOFO is expected to be published in summer of 2004 with an expected application due date in fall of 2024. This NOFO will utilize the UM1 activity code (Research Project with Complex Structure, Cooperative Agreement, Clinical Trial Optional). Details of the planned NOFO are provided below.
Application Deadline
Jun 1, 2024
Date Added
Apr 22, 2024
iHIT – Ideas – High-return, Innovative, Transformative o Supports ideas in bioscience research that are in the development stage and promise to have a high economic return for innovative and transformative research projects. o This mechanism intends to support applicants to develop novel lines of multidisciplinary research different from their ongoing research. o Up to $75,000 for 1 year.Proposal must be submitted as a single electronic PDF document at the link provided on the CAT website https://cat.dbi.udel.edu. Please note that submission and award processes have changed.
Application Deadline
Dec 1, 2024
Date Added
Apr 22, 2024
This funding opportunity supports innovative bioscience research projects in Delaware that have the potential for significant economic impact, targeting researchers and businesses in the developmental stage.
Application Deadline
May 10, 2024
Date Added
Apr 17, 2024
This application is part of the provisions under the 2004 Individuals with Disabilities Education Act (IDEA 2004), its implementing regulations, and the Regulations Governing Special Education Programs for Children with Disabilities in Virginia. It is the formal agreement between local school boards and the Virginia Department of Education (VDOE) to ensure compliance and implementation of federal and state laws concerning special education. The plan outlines the requirements for local educational agencies (LEAs) to receive state and Eligibility is limited to local educational agencies (LEAs), state-operated programs, and the Virginia School for the Deaf and the Blind. Compliance with IDEA and Virginia special education regulations is mandatory.federal funds for educating children with disabilities, necessitating approval from various educational and state bodies. Applications must be submitted electronically via the OMEGA system. Approval from local school boards, the State Special Education Advisory Committee, and respective educational bodies is required.
Application Deadline
Feb 3, 2025
Date Added
Apr 13, 2024
To support outstanding graduate students from diverse backgrounds, including those from groups underrepresented in biomedical, clinical, behavioral and social sciences, over the transition from predoctoral to postdoctoral research training.. This phased award program will facilitate completion of graduate PhD or dual degree clinician scientist programs (F99) and progression to mentored postdoctoral positions in dental, oral and craniofacial research (K00).
Application Deadline
Jul 22, 2024
Date Added
Apr 6, 2024
This is a non-competitive funding opportunity intended to fund a single award. NCATS is announcing its intent to issue a single source cooperative agreement to Cincinnati Childrens Hospital Medical Center (CCHMC) to support the Data Management and Coordinating Center. The Rare Diseases Clinical Research Network (RDCRN) is intended to advance and improve diagnosis, management, and treatment of numerous, diverse rare diseases through highly collaborative, multi-site, patient-centric, translational, and clinical research with an emphasis on early and timely identification of individuals with rare diseases and clinical trial readiness. The DMCC facilitates and supports the activities of each individual Rare Diseases Clinical Research Consortium (RDCRC) along with trans-network activities that broadly facilitate the advancement of rare disease research via four avenues: administrative support, data management support, clinical research support and patient engagement, and broad dissemination of information. The RDCRCs will continue conducting research conducted under a separate NOFO.
Application Deadline
Jun 25, 2024
Date Added
Mar 22, 2024
The National Institutes of Health (NIH) Institutes and Centers (ICs) intend to reissue a Notice of Funding Opportunity (NOFO) to continue the Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) program. The full list of participating ICs will be available in the published NOFO. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive applications. The NOFO is anticipated to be published in Spring 2024 with an expected first application due date in Summer 2024. The NOFO will utilize the R15 activity code. Pertinent details of the planned NOFO are provided below.
Application Deadline
Jun 25, 2024
Date Added
Mar 22, 2024
The National Institutes of Health (NIH) Institutes and Centers (ICs) intend to reissue a Notice of Funding Opportunity (NOFO) to continue the Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed) program. The full list of participating ICs will be available in the published NOFO. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive applications. The NOFO is anticipated to be published in Spring 2024 with an expected first application due date in Summer 2024. The NOFO will utilize the R15 activity code. Pertinent details of the planned NOFO are provided below.
Application Deadline
Sep 14, 2024
Date Added
Mar 22, 2024
The National Center for Advancing Translational Sciences (NCATS) intends to reissue the Notice of Funding Opportunity (NOFO) to solicit applications for the Clinical and Translational Science Award (CTSA) Program hubs that will be part of a national, collaborative consortium focused on bringing more treatments to more patients more quickly through advancing clinical and translational science (CTS). This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The NOFO is expected to be published in Summer 2024 with an expected application due date in January 2025. This NOFO will utilize the UM1 activity code. Details of the planned NOFO are provided below.
Application Deadline
Sep 3, 2024
Date Added
Mar 21, 2024
The Indiana Alcohol Research Center (IARC) is inviting proposals for pilot projects focusing on alcohol use disorders (AUD). This program aims to support investigators in generating preliminary data that can lead to extramural funding, with special interest in studies on the behavioral, biological, and genetic mechanisms of alcohol preference, binge-level and high-intensity drinking, tolerance, and other AUD-related mechanisms. The program offers up to $50,000 per year for two years, funding up to two projects. Priority is given to early-career investigators or those new to alcohol research, and applicants should be affiliated with the Indiana University system. The application process includes a letter of intent due by August 1, 2024, and a full proposal submission by September 3, 2024. Grant renewed every year. Project during 2 years
Application Deadline
Not specified
Date Added
Mar 21, 2024
This funding opportunity supports partnerships between universities and community organizations in Indiana to improve health outcomes and address social determinants of health through collaborative planning activities.
Application Deadline
May 1, 2024
Date Added
Mar 20, 2024
The Research Enhancement Grant (REG) is a program designed to boost research productivity at Indiana University School of Medicine’s statewide Centers for Medical Education, excluding the IUPUI campus. It targets faculty with Assistant, Associate, or Full Professor or Scientist titles, providing up to $50,000 for one-year projects. This initiative encourages scholarly and creative research activities, aiming to equip investigators for successful extramural research support acquisition. The program, funded by the School of Medicine with matching funds from regional campuses, anticipates awarding 2 grants each fiscal year.